Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Neoplasms and FPGS[original query] |
|---|
| Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. The American journal of clinical nutrition 2008 Oct 88 (4): 1149-58. DeVos Lauren, Chanson Aurelie, Liu Zhenhua, Ciappio Eric D, Parnell Laurence D, Mason Joel B, Tucker Katherine L, Crott Jimmy |
| Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer causes & control : CCC 2009 Dec . Figueiredo Jane C, Levine A Joan, Lee Won H, Conti David V, Poynter Jenny N, Campbell Peter T, Duggan David, Lewinger Juan Pablo, Martinez Maria Elena, Ulrich Cornelia M, Newcomb Polly, Potter John, Limburg Paul J, Hopper John, Jenkins Mark A, Le Marchand Loic, Baron John A, Haile Robert |
| Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Feb 28 (4): 614-9. Adjei Alex A, Mandrekar Sumithra J, Dy Grace K, Molina Julian R, Adjei Araba A, Gandara David R, Ziegler Katie L Allen, Stella Philip J, Rowland Kendrith M, Schild Steven E, Zinner Ralph |
| Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1346-53. Adjei Araba A, Salavaggione Oreste E, Mandrekar Sumithra J, Dy Grace K, Ziegler Katie L Allen, Endo Chiaki, Molina Julian R, Schild Steven E, Adjei Alex |
| Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Dec . Smit EF, Socinski MA, Mullaney BP, Myrand SP, Scagliotti GV, Lorigan P, Reck M, Ciuleanu T, von Pawel J, Karaseva NA, Szczesna A, Ohannesian D, Powell E, Hozak RR, Hong S, Guba SC, Thatcher N |
| A folylpoly-?-glutamate synthase single nucleotide polymorphism associated with response to pemetrexed treatment combined with platinum for non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2016 Dec 102 15-20. Fukuda Satoshi, Oguri Tetsuya, Kunii Eiji, Sone Kazuki, Uemura Takehiro, Takakuwa Osamu, Maeno Ken, Kanemitsu Yoshihiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Niimi Ak |
| Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon. Cancer chemotherapy and pharmacology 2021 Jul . Fernandes Marianne Rodrigues, Rodrigues Juliana Carla Gomes, Dobbin Elizabeth Ayres Fragoso, Pastana Lucas Favacho, da Costa Danielle Feio, Barra Williams Fernandes, Modesto Antônio André Conde, de Assumpção Paula Baraúna, da Costa Silva Artur Luiz, Dos Santos Sidney Emanuel Batista, Burbano Rommel Mario Rodriguez, de Assumpção Paulo Pimentel, Dos Santos Ney Pereira Carnei |
| Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax 2021 Apr . Visser Sabine, Koolen Stijn, van Donk Nadine, van Walree Nico, van der Leest Cor, Cornelissen Robin, van Schaik Ron, Mathijssen Ron, Aerts Joachim, Stricker Bruno |
| Effects of single nucleotide polymorphisms of the folylpolyglutamate synthase gene on pemetrexed administration-induced nephropathy. British journal of clinical pharmacology 2023 7 . Yuki Mitarai, Ryosuke Tanino, Kazuhisa Nakashima, Takamasa Hotta, Takeshi Isobe, Yukari Tsuba |
| Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study. JCO precision oncology 2023 3 7 e2200580. Larkin Trisha, Kashif Reema, Elsayed Abdelrahman H, Greer Beate, Mangrola Karna, Raffiee Roya, Nguyen Nam, Shastri Vivek, Horn Biljana, Lamba Jatinder |
- Page last reviewed:Feb 1, 2024
- Content source:

